| Literature DB >> 34612153 |
Bitao Chen1, Kejun Zhang2, Qinli Han1, Weiwei Zhong1, Jie Yi1, Huiling Zhu1, Shitao Xia1.
Abstract
Abundant researches have stated that long noncoding RNAs (lncRNAs) are crucial molecules in intricate progression of various cancers in terms of their influence on cell stemness. However, no research has discussed the role of LINC00460 in the stemness of hepatocellular carcinoma (HCC). RT-qPCR and western blot were utilized to respectively examine the RNA and protein levels. Aldehyde dehydrogenase 1 (ALDH1) assays and sphere formation assay were performed to detect cell stemness property in vitro and in vivo subcutaneous xenograft tumor assay was performed to detect tumor growth. Interaction between RNAs was explored by luciferase reporter assays and RNA pull-down assays. Our results showed that LINC00460 was markedly over-expressed in HCC and silencing LINC00460 impaired cell stemness. Additionally, LINC00460 knockdown curbed proliferation, migration, invasion and epithelial-to-mesenchymal transition (EMT) and drove apoptosis of HCC cells. Further, LINC00460 bound to miR-503-5p and miR-654-3p to protect t-complex 1 (TCP1) from being inhibited by miR-503-5p/miR-654-3p. Rescue experiments confirmed the effect of LINC00460/miR-503-5p/miR-654-3p/TCP1 on HCC cell stemness. In conclusion, LINC00460 aggravated cell stemness in HCC via targeting miR-503-5p/miR-654-3p and TCP1, suggesting that LINC00460 may work as a potential signature for cell stemness in HCC.[Figure: see text].Entities:
Keywords: LINC00460; TCP1; hepatocellular carcinoma; miR-503-5p; miR-654-3p; stemness
Mesh:
Substances:
Year: 2021 PMID: 34612153 PMCID: PMC8565821 DOI: 10.1080/15384101.2021.1940627
Source DB: PubMed Journal: Cell Cycle ISSN: 1551-4005 Impact factor: 5.173